Lumexa Imaging (NASDAQ:LMRI) was upgraded by analysts at Raymond James Financial, Inc. from an "outperform" rating to a "strong-buy" rating. They now have a $23.00 price target on the stock.
Lumexa Imaging's Dr. Jennifer L. Kemp Elected to RSNA Board, Advancing National Leadership in Quality and Patient-Centered Care [Yahoo! Finance]
Lumexa Imaging's Dr. Jennifer L. Kemp Elected to RSNA Board, Advancing National Leadership in Quality and Patient-Centered Care
Assessing Lumexa Imaging Holdings (LMRI) Valuation After Recent Share Price Pullback [Yahoo! Finance]
Lumexa Imaging Achieves Record De Novo Expansion in 2025 [Yahoo! Finance]